TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $662,000 | -54.7% | 26,891 | -55.4% | 0.03% | -48.3% |
| Q2 2022 | $1,462,000 | +163.4% | 60,355 | +180.4% | 0.06% | +200.0% |
| Q1 2022 | $555,000 | -47.3% | 21,525 | -36.6% | 0.02% | -47.4% |
| Q4 2021 | $1,053,000 | +12.5% | 33,925 | -12.1% | 0.04% | -7.3% |
| Q3 2021 | $936,000 | +69.6% | 38,588 | +2.0% | 0.04% | +86.4% |
| Q2 2021 | $552,000 | +19.2% | 37,824 | +103.9% | 0.02% | +15.8% |
| Q1 2021 | $463,000 | – | 18,546 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |